By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Diabetes has existed as a long-term health problem since the dawn of time, and with no treatment in sight, persons suffering from diabetes must rely on a variety of medical equipment as well as lifestyle changes to control symptoms.
According to University of Manchester research, the number of people with type 2 diabetes who received HbA1c tests, which provide information about blood sugar levels over time, fell in England, Northern Ireland, Scotland, and Wales during the country’s first lockdown in April.
Many people in the medical device and healthcare industries want to create an ecosystem through technology that allows patients to manage their diabetes and receive feedback.
One expert even revealed in a recent Forbes piece how certain medical technologists even provide a closed-loop system, in which an insulin pump gets information from a continuous glucose monitor (CGM) to instruct the dosage of insulin it needs to deliver into the body.
However, this degree of vigilance is normally reserved for the most severe instances of type-one diabetes; the following devices are available for people with a more controllable form or type-two diabetes.
For diabetics, the presence of ketones – molecules generated in the liver that are utilized for energy instead of carbs – might signal that the disease is not being properly managed by insulin administration. This is due to the fact that insulin permits the body to turn glucose into energy. Overproduction occurs in the most extreme circumstances.
Ketones can cause the blood to become acidic, resulting in diabetic ketoacidosis, which can lead to diabetic coma or even death.Although this is an uncommon occurrence, particularly among type 2 diabetics, gadgets that detect ketones are available to assist patients keep track of their ketone production and acquire a better knowledge of how they’re treating the illness.
Although a breathalyzer ketone test was inspired by a popular fitness fad, the ketogenic diet, devices that detect the compounds in blood and urine are regarded to be more accurate, making them more suited to diabetes management.Once a user has ingested alcohol, the breathalyzer is also known to be incorrect.
A diabetic patient’s blood glucose level is their key indicator of health.However, while doctors perform a HbA1c test to determine the average blood sugar level over a 6 to 12 week period, patients are also recommended to wear a blood glucose monitor between appointments.
These devices often need a blood sample taken using an included finger prick implement and provide a near-instant glucose measurement, providing patients with an indication of how effectively they’re treating the disease.A few glucose monitors on the market can also provide a ketone reading, making it easier for people who regulate their ketone levels to do so.
The continuous glucose monitor, a natural progression from the blood glucose monitor, involves inserting a sensor into a subcutaneous fat layer on the arm or stomach.Once implanted, the sensor connects with a transmitter put above it, which, in the most recent models, tends to communicate with a smartphone through Bluetooth.
If the transmitter detects that blood glucose levels are too low or too high, it will sound an alert, and the app it partners with will provide patients with further information about their glucose levels and what they may do to boost or decrease them as needed.One of the benefits of continually monitoring glucose is that data from the app may be shared with a physician to provide insight.
In type one diabetes, the more severe of the two main forms, the body cannot physically generate insulin in the pancreas as it should.This implies that individuals with the condition must inject themselves with insulin multiple times each day, which can be made easier by using a pump.An insulin pump is a small electronic device that is attached to a cannula that is placed into the body.
generally on the side of the stomach around the waist.The pump may be programmed to administer tiny amounts of short-acting insulin over time, simulating pancreatic function.However, in the closed-loop system described above, a pump can also be linked to a continuous glucose monitor.
The Europe Diabetes Care Medical Device Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Ascensia Diabetes Care, a global diabetes care company and distributor of Eversense Continuous Glucose Monitoring (CGM) Systems, announces that its partner Sen seonics Holdings, Inc. has received CE Mark approval for the Eversense E3 Continuous Glucose Monitoring (CGM) System, paving the way for its use in European Union (EU) member countries.
From the third quarter, Ascensia intends to make the next-generation system, which may be used for up to six months, available to patients in select European regions .The completely implanted, long-term Ever sense E3 CGM System has been intended to bring significant enhancements over the current Ever sense XL CGM System.
while expanding on the particular benefits that European users now enjoy. The next-generation system provides remarkable performance. The next-generation technology provides remarkable precision and long-term sensor wear, as well as reduced calibration frequency and greatly improved sensor survival. Unlike the XL System, the new E3 System is also certified for non-adjunctive usage, which means it may influence insulin treatment decisions without the need for fingerstick testing to confirm glucose levels.
Ever sense XL and Ever sense E3 are both authorized for usage for up to 6 months, making them the most durable CGM sensors on the market. This frees diabetics from the responsibilities associated with other existing CGM systems, such as weekly or biweekly self-insertions.
Ever sense E3 is already accessible in the United States, having received FDA approval and being released earlier this year. Following CE Mark clearance in Europe, the Ever sense E3 System will be supplied in the United States.
